These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34511064)

  • 1. Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belém, Pará, Amazonia, Brazil.
    da Silva HP; Abreu IN; Lima CNC; de Lima ACR; do Nascimento Barbosa A; de Oliveira LR; Fujishima MA; Lima SS; de Lima VN; Castelo-Branco S; Vallinoto ACR
    BMC Public Health; 2021 Sep; 21(1):1659. PubMed ID: 34511064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-1 and HTLV-2 Infection Among Warao Indigenous Refugees in the Brazilian Amazon: Challenges for Public Health in Times of Increasing Migration.
    Abreu IN; Lopes FT; Lima CNC; Barbosa ADN; de Oliveira LR; Fujishima MA; Freitas FB; Dos Santos MB; de Lima VN; Cayres-Vallinoto IMV; Castelo-Branco S; da Silva HP; Vallinoto ACR
    Front Public Health; 2022; 10():833169. PubMed ID: 35223744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon.
    Rodrigues EPS; Abreu IN; Lima CNC; da Fonseca DLM; Pereira SFG; Dos Reis LC; Vallinoto IMVC; Guerreiro JF; Vallinoto ACR
    Int J Equity Health; 2021 Jan; 20(1):50. PubMed ID: 33509206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study.
    Lima CNC; Abreu IN; Rodrigues EPS; Freitas VO; Botelho BJS; Souza SL; Cayres-Vallinoto I; Guerreiro JF; Ishak R; Vallinoto ACR
    BMJ Open; 2022 Feb; 12(2):e054271. PubMed ID: 35131827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the seroprevalence and risk factors between the first and second waves of COVID-19 in a metropolis in the Brazilian Amazon.
    da Silva Torres MK; Lopes FT; de Lima ACR; Cordeiro Lima CN; Dos Santos Brito WR; Gonçalves JSS; Dos Santos Oliveira O; de Oliveira Freitas V; Dos Santos BC; Santos de Sousa R; Carvalho Gomes JL; Sarmento Botelho BJ; Alves Correa AC; Machado LFA; Martins Feitosa RN; Lima SS; Cayres Vallinoto IMV; Vallinoto ACR
    Front Cell Infect Microbiol; 2022; 12():932563. PubMed ID: 36189360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and risk factors for COVID-19 in the metropolis of the Brazilian Amazon.
    da Silva Torres MK; Lopes FT; de Lima ACR; Lima CNC; Dos Santos Brito WR; Dos Santos BC; de Sousa RS; Gomes JLC; Botelho BJS; Correa ACA; Machado LFA; Feitosa RNM; Lima SS; Vallinoto IMVC; Vallinoto ACR
    Sci Rep; 2022 May; 12(1):8571. PubMed ID: 35595782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for COVID-19: a few points to remember.
    Krátká Z; Luxová Š; Malíčková K; Fürst T; Šimková H
    Cas Lek Cesk; 2020; 159(2):72-77. PubMed ID: 32434339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.
    Pontes GS; de Melo Silva J; Pinheiro-Silva R; Barbosa AN; Santos LC; de Pádua Quirino Ramalho A; de Castro Alves CE; da Silva DF; de Oliveira LC; da Costa AG; Bruno AC
    Sci Rep; 2021 Sep; 11(1):17534. PubMed ID: 34475438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned.
    Poljak M; Oštrbenk Valenčak A; Štrumbelj E; Maver Vodičar P; Vehovar V; Resman Rus K; Korva M; Knap N; Seme K; Petrovec M; Zupan B; Demšar J; Kurdija S; Avšič Županc T
    Clin Microbiol Infect; 2021 Jul; 27(7):1039.e1-1039.e7. PubMed ID: 33838303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
    Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
    JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
    Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
    PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
    Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
    PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
    Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
    Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
    J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.